GMAB:NASDAQ
Genmab
27,04 US$
arrow_upward
+2,23%(+0,59) 1K
27,04 US$
0,00% (0,00)
bedtimeYopilgandan keyin
Savdolar yopilgan: 4-may, 16:00:01 (GMT-4) · USD
search
Barcha belgilar
1K
5K
1O
6O
YBB
1Y
5Y
MAKS
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoGMAB tikeri uchun statistika yaratilmoqda...
Ochish
26,30 US$
Yuqori
27,08 US$
Past
26,24 US$
Bozor kapitali
16,79 mlrd
Oʻrtacha hajm
1,65 mln
Hajmi
1,20 mln
P/E koeffitsiyenti
17,60
52 haftalik eng yuqori
35,43 US$
52 haftalik eng past
18,88 US$
Aksiya boʻyicha daromad
1,54 US$
Beta
0,86
Muomaladagi aksiyalar
623,51 mln
Xodimlar soni
3 ming
Yangiliklar
Internetdagi manbalardan
HarianBasis.co
·
2 kun oldin
Genmab Secures Outperform Rating Following Q1 Revenue Growth
Yahoo Finance
·
2 kun oldin
Genmab (GMAB) Rated Outperform on Oncology Pipeline
Profil
Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. The company is based in Copenhagen, Denmark – internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, The Netherlands, Genmab U.S., Inc. in Princeton, New Jersey, US, Genmab K.K. in Tokyo, Japan, Genmab Germany GmbH in München, Germany and Genmab Co., Ltd. in Suzhou, China. Genmab is listed on the Copenhagen Stock Exchange in Denmark, with American depositary receipts traded on the NASDAQ in the US. Wikipedia
Genmab haqida
CEOJan G. J. van de Winkel
Xodimlar soni2,97 ming
Asos solingan1999
Bosh ofislar-
Sektor-
Veb-saytgenmab.com
AI kontentda xatolar boʻlishi mumkin. Batafsil